Non-hormonal interventions for hot flushes in women with a history of breast cancer (Q24235391)

2

0 references

Gabriel Rada

object named as

Gabriel Rada

1

0 references

author name string

Javiera Corbalán

4

0 references

Gladys Moreno

5

0 references

Luz M Letelier

6

0 references

Claudio Vera

Cochrane Database of Systematic Reviews

7

0 references

publication date

8 September 2010

0 references

published in

0 references

cites work

A pilot study of magnetic therapy for hot flashes after breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

A Randomized Controlled Trial of Relaxation Training to Reduce Hot Flashes in Women with Primary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

A pilot, randomized, double-blinded, placebo-controlled trial of individualized homeopathy for symptoms of estrogen withdrawal in breast-cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

21 January 2018

Alternatives to estrogen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Hot flashes: behavioral treatments, mechanisms, and relation to sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Clinical practice. Management of menopausal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Increased risk of recurrence after hormone replacement therapy in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Symptom management in premenopausal patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Newer antidepressants for hot flashes--should their efficacy still be up for debate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Acute menopause symptoms during adjuvant systemic treatment for breast cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

The menopausal hot flush--anything new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

A study to look at the effects of a hydrolat spray on hot flushes in women being treated for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

7 January 2021

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

7 January 2021

Relaxation therapy as an intervention for hot flushes in women with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

7 January 2021

Transdermal clonidine for ameliorating tamoxifen-induced hot flashes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

7 January 2021

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

7 January 2021

Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004923.PUB2

7 January 2021

10.1002/14651858.CD004923.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3132142

3132142

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference